biospecimen_aliquot__bcr_aliquot_barcode	tcga-a2-a0ye-01a-11d-a10g-09
biospecimen_aliquot__bcr_aliquot_uuid	3a4ca2a3-9918-465b-823f-403419bd9740
biospecimen_aliquot__bcr_patient_uuid	84a88e8d-1e65-4b88-aae6-bf4c7a7e4c33
biospecimen_aliquot__bcr_sample_barcode	tcga-a2-a0ye-01a
biospecimen_aliquot__biospecimen_barcode_bottom	0099016194
biospecimen_aliquot__center_id	09
biospecimen_aliquot__concentration	0.08
biospecimen_aliquot__date_of_shipment	2010-11-22
biospecimen_aliquot__is_derived_from_ffpe	no
biospecimen_aliquot__plate_column	4
biospecimen_aliquot__plate_id	a10g
biospecimen_aliquot__plate_row	g
biospecimen_aliquot__quantity	2.08
biospecimen_aliquot__source_center	23
biospecimen_aliquot__volume	26.00
biospecimen_analyte__a260_a280_ratio	2.03
biospecimen_analyte__analyte_type	dna
biospecimen_analyte__analyte_type_id	d
biospecimen_analyte__bcr_analyte_barcode	tcga-a2-a0ye-01a-11d
biospecimen_analyte__bcr_analyte_uuid	339d64b6-8c0f-43af-bbd6-1d453bf5bd9f
biospecimen_analyte__bcr_patient_uuid	84a88e8d-1e65-4b88-aae6-bf4c7a7e4c33
biospecimen_analyte__bcr_sample_barcode	tcga-a2-a0ye-01a
biospecimen_analyte__concentration	0.16
biospecimen_analyte__gel_image_file	https://sharedoc.nchri.org/tcga-bcr/default.aspx
biospecimen_analyte__is_derived_from_ffpe	no
biospecimen_analyte__normal_tumor_genotype_match	yes
biospecimen_analyte__pcr_amplification_successful	yes
biospecimen_analyte__spectrophotometer_method	uv spec
biospecimen_analyte__subportion_sequence	1
biospecimen_diagnostic_slides__bcr_patient_barcode	tcga-a2-a0ye
biospecimen_diagnostic_slides__bcr_patient_uuid	84a88e8d-1e65-4b88-aae6-bf4c7a7e4c33
biospecimen_diagnostic_slides__bcr_sample_barcode	tcga-a2-a0ye-01a
biospecimen_diagnostic_slides__ffpe_slide_uuid	8a2e3094-5755-42bc-969d-7f0a2eca0f39
biospecimen_normal_control__bcr_patient_barcode	tcga-a2-a0ye
biospecimen_normal_control__bcr_patient_uuid	84a88e8d-1e65-4b88-aae6-bf4c7a7e4c33
biospecimen_normal_control__ncedna_dna_conc	0.124
biospecimen_normal_control__ncedna_dna_qm	spec (nanodrop)
biospecimen_normal_control__ncedna_dna_qty	20
biospecimen_normal_control__ncedna_dna_vol	161.3
biospecimen_portion__bcr_patient_uuid	84a88e8d-1e65-4b88-aae6-bf4c7a7e4c33
biospecimen_portion__bcr_portion_barcode	tcga-a2-a0ye-01a-11
biospecimen_portion__bcr_portion_uuid	183036c5-ff12-46d7-9815-b4fee70e6232
biospecimen_portion__bcr_sample_barcode	tcga-a2-a0ye-01a
biospecimen_portion__date_of_creation	2010-10-18
biospecimen_portion__is_ffpe	no
biospecimen_portion__portion_number	11
biospecimen_portion__portion_sequence	1
biospecimen_portion__weight	30.00
biospecimen_protocol__bcr_analyte_barcode	tcga-a2-a0ye-01a-11d
biospecimen_protocol__bcr_patient_uuid	84a88e8d-1e65-4b88-aae6-bf4c7a7e4c33
biospecimen_protocol__bcr_sample_barcode	tcga-a2-a0ye-01a
biospecimen_protocol__experimental_protocol_type	adna preparation type
biospecimen_sample__bcr_patient_uuid	84a88e8d-1e65-4b88-aae6-bf4c7a7e4c33
biospecimen_sample__bcr_sample_barcode	tcga-a2-a0ye-01a
biospecimen_sample__bcr_sample_uuid	c8426c95-e975-4a7e-9943-f5c513dd95ef
biospecimen_sample__days_to_collection	238
biospecimen_sample__initial_weight	240
biospecimen_sample__is_ffpe	no
biospecimen_sample__oct_embedded	true
biospecimen_sample__pathology_report_file_name	tcga-a2-a0ye.c58701ef-98c4-448e-978c-b39d125cc7e8.pdf
biospecimen_sample__pathology_report_uuid	c58701ef-98c4-448e-978c-b39d125cc7e8
biospecimen_sample__sample_type	primary tumor
biospecimen_sample__sample_type_id	01
biospecimen_sample__vial_number	a
biospecimen_shipment_portion__bcr_patient_uuid	84a88e8d-1e65-4b88-aae6-bf4c7a7e4c33
biospecimen_shipment_portion__bcr_sample_barcode	tcga-a2-a0ye-01a
biospecimen_shipment_portion__bcr_shipment_portion_uuid	510563aa-4a19-4dd1-82c8-ac67f8a77a55
biospecimen_shipment_portion__center_id	20
biospecimen_shipment_portion__is_ffpe	no
biospecimen_shipment_portion__plate_id	a13d
biospecimen_shipment_portion__portion_number	21
biospecimen_shipment_portion__portion_sequence	2
biospecimen_shipment_portion__shipment_portion_bcr_aliquot_barcode	tcga-a2-a0ye-01a-21-a13d-20
biospecimen_shipment_portion__shipment_portion_day_of_shipment	22
biospecimen_shipment_portion__shipment_portion_month_of_shipment	3
biospecimen_shipment_portion__shipment_portion_year_of_shipment	2011
biospecimen_slide__bcr_patient_uuid	84a88e8d-1e65-4b88-aae6-bf4c7a7e4c33
biospecimen_slide__bcr_sample_barcode	tcga-a2-a0ye-01a
biospecimen_slide__bcr_slide_barcode	tcga-a2-a0ye-01a-01-bs1
biospecimen_slide__bcr_slide_uuid	7203b6fc-3a45-41e1-9104-14255fe4eb6e
biospecimen_slide__image_file_name	tcga-a2-a0ye-01a-01-bs1.7203b6fc-3a45-41e1-9104-14255fe4eb6e.svs
biospecimen_slide__is_derived_from_ffpe	no
biospecimen_slide__percent_lymphocyte_infiltration	3
biospecimen_slide__percent_monocyte_infiltration	1
biospecimen_slide__percent_necrosis	2
biospecimen_slide__percent_neutrophil_infiltration	1
biospecimen_slide__percent_normal_cells	0
biospecimen_slide__percent_stromal_cells	18
biospecimen_slide__percent_tumor_cells	80
biospecimen_slide__percent_tumor_nuclei	80
biospecimen_slide__section_location	bottom
biospecimen_tumor_sample__bcr_patient_barcode	tcga-a2-a0ye
biospecimen_tumor_sample__bcr_patient_uuid	84a88e8d-1e65-4b88-aae6-bf4c7a7e4c33
clinical_drug__bcr_drug_barcode	tcga-a2-a0ye-d5669
clinical_drug__bcr_drug_uuid	635760ed-24dd-4491-bd61-c6793eb02a35
clinical_drug__bcr_patient_barcode	tcga-a2-a0ye
clinical_drug__bcr_patient_uuid	84a88e8d-1e65-4b88-aae6-bf4c7a7e4c33
clinical_drug__form_completion_date	2010-12-8
clinical_drug__pharma_adjuvant_cycles_count	5
clinical_drug__pharmaceutical_therapy_drug_name	adriamycin
clinical_drug__pharmaceutical_therapy_type	chemotherapy
clinical_drug__pharmaceutical_tx_ongoing_indicator	no
clinical_drug__regimen_number	2
clinical_drug__route_of_administration	iv
clinical_drug__therapy_regimen	adjuvant
clinical_follow_up__bcr_followup_barcode	tcga-a2-a0ye-f15771
clinical_follow_up__bcr_followup_uuid	7d263191-4081-4dd8-9e46-6d37d7714745
clinical_follow_up__bcr_patient_barcode	tcga-a2-a0ye
clinical_follow_up__bcr_patient_uuid	84a88e8d-1e65-4b88-aae6-bf4c7a7e4c33
clinical_follow_up__followup_reason	scheduled follow-up submission
clinical_follow_up__form_completion_date	2011-8-30
clinical_follow_up__last_contact_days_to	554
clinical_follow_up__new_tumor_event_dx_indicator	no
clinical_follow_up__radiation_treatment_adjuvant	yes
clinical_follow_up__targeted_molecular_therapy	yes
clinical_follow_up__tumor_status	tumor free
clinical_follow_up__vital_status	alive
clinical_patient__age_at_diagnosis	48
clinical_patient__ajcc_metastasis_pathologic_pm	m0
clinical_patient__ajcc_nodes_pathologic_pn	n1a
clinical_patient__ajcc_pathologic_tumor_stage	stage iib
clinical_patient__ajcc_tumor_pathologic_pt	t2
clinical_patient__anatomic_neoplasm_subdivision	right upper outer quadrant
clinical_patient__axillary_staging_method	sentinel lymph node biopsy plus axillary dissection
clinical_patient__bcr_patient_barcode	tcga-a2-a0ye
clinical_patient__bcr_patient_uuid	84a88e8d-1e65-4b88-aae6-bf4c7a7e4c33
clinical_patient__birth_days_to	-17727
clinical_patient__days_to_initial_pathologic_diagnosis	0
clinical_patient__er_status_by_ihc	negative
clinical_patient__er_status_ihc_Percent_Positive	<10%
clinical_patient__ethnicity	not hispanic or latino
clinical_patient__form_completion_date	2010-12-10
clinical_patient__gender	female
clinical_patient__her2_ihc_percent_positive	<10%
clinical_patient__her2_ihc_score	0
clinical_patient__her2_positivity_method_text	no membrane staining or incomplete membrane staining in <10% of tumor cells is negative
clinical_patient__her2_status_by_ihc	negative
clinical_patient__histological_type	infiltrating ductal carcinoma
clinical_patient__history_neoadjuvant_treatment	no
clinical_patient__history_other_malignancy	no
clinical_patient__icd_10	c50.9
clinical_patient__icd_o_3_histology	8500/3
clinical_patient__icd_o_3_site	c50.9
clinical_patient__informed_consent_verified	yes
clinical_patient__initial_pathologic_dx_year	2010
clinical_patient__last_contact_days_to	253
clinical_patient__lymph_nodes_examined_count	19
clinical_patient__lymph_nodes_examined_he_count	1
clinical_patient__margin_status	negative
clinical_patient__menopause_status	post (prior bilateral ovariectomy or >12 mo since lmp with no prior hysterectomy)
clinical_patient__method_initial_path_dx	core needle biopsy
clinical_patient__micromet_detection_by_ihc	no
clinical_patient__patient_id	a0ye
clinical_patient__pr_status_by_ihc	negative
clinical_patient__pr_status_ihc_percent_positive	<10%
clinical_patient__prospective_collection	no
clinical_patient__race	white
clinical_patient__retrospective_collection	yes
clinical_patient__surgical_procedure_first	lumpectomy
clinical_patient__tissue_source_site	a2
clinical_patient__tumor_status	tumor free
clinical_patient__tumor_tissue_site	breast
clinical_patient__vital_status	alive
clinical_radiation__bcr_patient_barcode	tcga-a2-a0ye
clinical_radiation__bcr_patient_uuid	84a88e8d-1e65-4b88-aae6-bf4c7a7e4c33
clinical_radiation__bcr_radiation_barcode	tcga-a2-a0ye-r5671
clinical_radiation__bcr_radiation_uuid	2fe7a331-456c-44f1-913e-6bb5abdea657
clinical_radiation__course_number	1
clinical_radiation__form_completion_date	2010-12-8
clinical_radiation__radiation_adjuvant_fractions_total	30
clinical_radiation__radiation_adjuvant_units	cgy
clinical_radiation__radiation_therapy_ended_days_to	267
clinical_radiation__radiation_therapy_ongoing_indicator	no
clinical_radiation__radiation_therapy_site	primary tumor field
clinical_radiation__radiation_therapy_started_days_to	225
clinical_radiation__radiation_therapy_type	external beam
clinical_radiation__radiation_total_dose	6000
clinical_radiation__therapy_regimen	adjuvant
manually_curated__center	genome.wustl.edu
manually_curated__dataType	dnaseq
manually_curated__exp_data_bed_url	ftp://bioinf.iasi.cnr.it/bed/brca/dnaseq/TCGA-A2-A0YE-01A-11D-A10G-09.bed
manually_curated__exp_metadata_url	ftp://bioinf.iasi.cnr.it/bed/brca/dnaseq/TCGA-A2-A0YE-01A-11D-A10G-09.bed.meta
manually_curated__id	tcga-a2-a0ye-01a-11d-a10g-09
manually_curated__md5sum	d16fb02783df667bc2558f11ac8ba143
manually_curated__ncbi_build	37
manually_curated__seqPlatform	illumina_ga2
manually_curated__sequence_source	wxs
manually_curated__sequencer	illumina gaiix
manually_curated__tissue_status	tumoral
manually_curated__tumor_description	breast invasive carcinoma
manually_curated__tumor_sample_uuid	3a4ca2a3-9918-465b-823f-403419bd9740
manually_curated__tumor_tag	brca
